Better living through chemistry: Addressing emerging antibiotic resistance

被引:9
|
作者
Coussens, Nathan P. [1 ]
Molinaro, Ashley L. [2 ]
Culbertson, Kayla J. [2 ]
Peryea, Tyler [1 ]
Zahornszky-Kohalmi, Gergely [1 ]
Hall, Matthew D. [1 ]
Daines, Dayle A. [2 ]
机构
[1] Natl Ctr Adv Translat Sci, Div Preclin Innovat, Rockville, MD 20850 USA
[2] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA
基金
美国国家卫生研究院;
关键词
Bacteria; drugs; mechanisms; pharmacology; resistance; small molecule inhibitors; SPECTRUM BETA-LACTAMASE; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; EFFLUX PUMPS; STREPTOCOCCUS-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; CARBAPENEM RESISTANCE; BACTERIAL-RESISTANCE; DRUG-COMBINATIONS; RISK;
D O I
10.1177/1535370218755659
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The increasing emergence of multidrug-resistant bacteria is recognized as a major threat to human health worldwide. While the use of small molecule antibiotics has enabled many modern medical advances, it has also facilitated the development of resistant organisms. This minireview provides an overview of current small molecule drugs approved by the US Food and Drug Administration (FDA) for use in humans, the unintended consequences of antibiotic use, and the mechanisms that underlie the development of drug resistance. Promising new approaches and strategies to counter antibiotic-resistant bacteria with small molecules are highlighted. However, continued public investment in this area is critical to maintain an edge in our evolutionary "arms race" against antibioticresistant microorganisms.
引用
收藏
页码:538 / 553
页数:16
相关论文
共 50 条